Skip to main content

Infigratinib



General

Pronunciation

(IN fig RA ti nib)

Brand Names: U.S.

  • Truseltiq (100MG Daily Dose)
  • Truseltiq (125MG Daily Dose)
  • Truseltiq (50MG Daily Dose)
  • Truseltiq (75MG Daily Dose)

Indications

Use: Labeled Indications

Cholangiocarcinoma, unresectable locally advanced or metastatic: Treatment of previously treated, unresectable locally advanced or metastatic cholangiocarcinoma in adults with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an approved test.

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

×